About Tarsons
Tarsons is a publicly listed company based in Kolkata (India) founded in 1983. It operates as a manufacturer of plastic labware and life science products. The company has 906 employees. Tarsons has completed 1 acquisition, including nerbe plus. Its website tarsons.com draws about 42 thousand monthly visits. Its Indian entity Tarsons Products Limited reported revenue of ₹408 Cr. Tarsons offers products and services including Plastic Labware and Centrifuge Ware.
Company details
Tarsons was founded in 1983 in Kolkata, India, as a manufacturer of plastic labware and life science items. Operations focus on producing disposable labware, centrifuge components, cryogenic storage, tissue culture vessels, liquid handling tools, safety equipment, and related instruments. Customization is achieved through plastic molding expertise and knowledge of lab protocols. Sectors served include healthcare, pharmaceuticals, biotechnology, food processing, and environmental testing.
- Headquarters Kolkata, India
- Employees 906
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tarsons.com
- Social LinkedIn X Facebook Instagram
- Legal Name Tarsons Products Limited
- Annual Revenue₹408 Cr
FY 2025 · +33% YoY
- Net Profit₹29.77 Cr
FY 2025 · 7% margin
- EBITDA₹127 Cr
FY 2025 · 31% margin
- Investors
- Employee Count906
- Investments & Acquisitions
Associated legal entities of Tarsons
Tarsons operates through Tarsons Products Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Tarsons Products Limited Listed CIN L51109WB1983PLC036510 | Active | 05 Jul 1983 | Kolkata, West Bengal | ₹408 Cr | 872 | 9 | View details |
Products & Services of Tarsons
Tarsons offers a comprehensive portfolio of products and services, including Plastic Labware and Centrifuge Ware.
Plastic labware is produced for scientific research in life sciences sectors.
Centrifuge ware is developed for sample processing in laboratory environments.
Funding Insights of Tarsons
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Tarsons with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | – | Private Equity Round | – | ADV Partners | – |
1 investors in total: 1 institutional.
Investors in Tarsons
Tarsons has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ADV Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments in Asia are managed by ADV Partners. | – | advpartners.com | Hong Kong, China |
Investor details for Tarsons
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Tarsons Products Limited (Tarsons)
Tarsons Products Limited is the primary company behind Tarsons. The board of Tarsons Products Limited currently have 8 directors; the longest-serving is Sanjive Sehgal, appointed in 1983. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjive Sehgal DIN 00787232 | Managing Director | 25 Jul 1983 | 43 yrs 2 mo | Tarsons Products Limited |
| Aryan Sehgal DIN 06963013 | Whole-time director | 01 Sep 2014 | 12 yrs 1 mo | Tarsons Products Limited |
| Viresh Oberai DIN 00524892 | Director | 20 Nov 2018 | 7 yrs 10 mo | Tarsons Products Limited |
| Suresh Eshwara Prabhala DIN 02130163 | Director | 15 Aug 2024 | 2 yrs 2 mo | Tarsons Products Limited |
| Divya Sameer Momaya DIN 00365757 | Director | 24 May 2025 | 1 yr 4 mo | Tarsons Products Limited |
| Subramanian Arun Kumar DIN 09101691 | Nominee Director | 04 Aug 2025 | 1 yr 2 mo | Tarsons Products Limited |
| Monjori Mitra DIN 02761691 | Director | 04 Aug 2025 | 1 yr 2 mo | Tarsons Products Limited |
| Vinesh Mohan Kriplani DIN 08212644 | Director | 06 Feb 2026 | 8 mo | Tarsons Products Limited |
People of Tarsons
21 people are tracked at Tarsons (8 in leadership, 13 in team); the tracked headcount is 906.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership | |
Priyanka Jain | Head Of Finance Accounts | Leadership |
Avijit Rakshit | IT HEAD | Leadership |
Santosh Agarwal | CFO & Company Secretary | Leadership |
Partha P Dubey | General Manager Sales - India & South Asia | Leadership |
Arup Chakraborty | General Manager International Business- APAC & Latam | Leadership |
Tarsons Products Limited | Director Life Science | Leadership |
George Serrano | Chief Marketing Officer, Global Strategic Partners | Leadership |
Aritra Paul | Sales Executive Of Governments E-marketplace (gem) & Domestic Tenders | Team |
Ca Manoj Kumar Saha | Manager - Accounts And Finance | Team |
Dr Balachandar S | Sr. Manager R&d | Team |
Rama Sharma | Assistant Company Secretary | Team |
Swami Naidu Pasadi | SAP Project Manager | Team |
Govind Gupta | Senior Manager Finance | Team |
Partha Das | Information Technology Executive | Team |
Ankan Samanta | Senior Officer At Quality Control | Team |
Ashmita Mahalanabish | Product Quality Management/technical Writer | Team |
Khushboo Mohata | Secretary Associate | Team |
Saswati Roy | Deputy Manager Human Resources | Team |
Sanjib Dey. | Senior Manager | Team |
1 more people are available in the full profile.
Complete people profiles for Tarsons
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Tarsons
Tarsons is a publicly listed company on the NSE with ticker symbol TARSONS in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date26 Nov 2021
- Listed onBSE: 543399 · NSE: TARSONS
- Listed entityTarsons Products Limited
- Exchange sectorProcess industries
- ISININE144Z01023
- Share price₹348.00 (+3.34% on the day) · 2026-10-14
- Market capitalisation₹1,797 Cr
- Price to earnings166.5
- EPS (diluted, trailing year)₹2.09
- Volume (last session)43,272
Financials of Tarsons
Figures of Tarsons Products Limited, the primary company behind Tarsons, for FY 2025. Revenue was ₹408 Cr (+33% year on year). Net profit was ₹29.77 Cr (7% margin). EBITDA was ₹127 Cr (31% margin). Revenue has grown at a compounded annual rate of +10% over three years and +18% over five years.
- ₹408 CrRevenue · FY 2025 · +33% YoY
- ₹29.77 CrNet profit · 7% margin
- ₹127 CrEBITDA · 31% margin
- ₹10.64 CrPaid-up capital
- 872Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹423 Cr | ₹14.3 Cr | ₹118 Cr |
| 2024 | ₹392 Cr | ₹29.8 Cr | ₹113 Cr |
| 2023 | ₹296 Cr | ₹42.6 Cr | ₹102 Cr |
| 2022 | ₹283 Cr | ₹80.7 Cr | ₹132 Cr |
| 2021 | ₹301 Cr | ₹101 Cr | ₹154 Cr |
Balance sheet, profit and loss, cash flow and ratios of Tarsons Products Limited are on its company page.
Detailed financial statements for Tarsons
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tarsons
Tarsons has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include nerbe plus.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Laboratory plastics are supplied to the global research industry. | nerbe-plus.de | Winsen, Germany | 1976 | Mar 2024 | •••• |
Complete acquisition details for Tarsons
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Tarsons
4 dated milestones of Tarsons across 41 years, from founding to its latest funding, stage changes and deals.
- Founded Tarsons is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires nerbe plus.
Web traffic of Tarsons
The website of Tarsons (tarsons.com) receives about 41.6K visits a month.
- Monthly visits41.6K
▼ 5.4% vs previous month
Websites whose visitors overlap most with Tarsons. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| himedialabs.com | 100% | 284.7K | #167,428 | View details | |
| biomall.in | 77% | 40.3K | #660,033 | View details | |
| remilabworld.com | 62% | 21.4K | #1,369,572 | View details | |
| avantorsciences.com | 56% | 564.1K | #77,334 | View details | |
| iitk.ac.in | 56% | 4.4M | #16,286 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Tarsons
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Tarsons (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tarsons
Complete news archive for Tarsons
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tarsons
Tarsons was founded in 1983 and raised its 1st funding round 35 years after it was founded.
Tarsons is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
Tarsons has 906 employees.
The primary company behind Tarsons, Tarsons Products Limited, reported revenue of ₹408 Cr for FY 2025, up 33% year on year.
Tarsons was founded in 1983 in Kolkata, India, as a manufacturer of plastic labware and life science items. Operations focus on producing disposable labware, centrifuge components, cryogenic storage, tissue culture vessels, liquid handling tools, safety equipment, and related instruments. Customization is achieved through plastic molding expertise and knowledge of lab protocols. Sectors served include healthcare, pharmaceuticals, biotechnology, food processing, and environmental testing.
Tarsons offers Plastic Labware and Centrifuge Ware.
Yes, Tarsons is publicly traded on NSE under the ticker symbol TARSONS.
Tarsons has made 1 acquisition, including nerbe plus.
Tarsons has 1 investor. Key investors include ADV Partners.
Tarsons operates through Tarsons Products Limited.
The legal entities of Tarsons currently have 9 directors, including Sanjive Sehgal, Subramanian Arun Kumar, Viresh Oberai and others.